Radionetics Oncology · 2 hours ago
Scientist I/II (In Vivo Biology)
San Diego, CA
Full-time
Onsite
Entry, Mid Level
$124K/yr - $147K/yrRadionetics Oncology, Inc. is a clinical stage radiopharmaceutical company focused on the discovery and development of novel radiopharmaceuticals for oncology. The Scientist I/II will contribute to in vivo pharmacology studies, analyze data, and support lead compound identification across multiple research programs.
Health CareMedicalOncologyPharmaceuticalTherapeutics
Responsibilities
Major focus in contributions to planning, execution, QC, data analysis, management and reporting of rodent in vivo pharmacology studies to demonstrate translational biodistribution and efficacy in oncology
Independently analyze, interpret and present data using graphing and analysis software programs
Ability to effectively communicate and present summaries of research results to team members or to a multi-disciplinary team of researchers
Experience managing external studies at, and collaborating with, Contract Research Organizations is preferred
Support a multi-disciplinary team developing in vivo team timelines
Participate and aid in execution of in vivo team goals
Experience in nuclear medicine and/or targeted radionuclide therapy including radiochemistry, dosimetry, and imaging is highly preferred
Maintain electronic lab notebooks, databases, and any other required recordkeeping
Maintain a work environment focused on scientific integrity and quality
Perform other duties as required by business needs
Qualification
Required
Ph.D. degree in biology or a related scientific discipline or M.Sc. or Bachelors with comparable experience
Relevant hands-on laboratory experience, with rodent tumor models/cancer pharmacology, and preferably in an industry setting
Ability to work independently and in a team environment
Desire and ability to expand knowledge and skills in a broad range of techniques
Maintain a work environment focused on scientific integrity and quality
Preferred
Experience managing external studies at, and collaborating with, Contract Research Organizations
Experience in nuclear medicine and/or targeted radionuclide therapy including radiochemistry, dosimetry, and imaging
Experience with software programs such as GraphPad Prism, Excel, and PowerPoint
Benefits
Bonus opportunity
Equity
Medical, dental, vision, life, short-term, and long-term disability insurance
401(k) retirement plan with employer match
4 weeks of paid time off (PTO) annually
Generous paid holidays
Company
Radionetics Oncology
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Founded in 2021
11-50 employees
Funding
Current Stage
Early StageTotal Funding
$82.5MKey Investors
5AM Ventures,DCVC Bio,Frazier Life Sciences5AM Ventures,Frazier Healthcare Partners
2023-08-14Series A· $52.5M
2021-10-18Seed· $30M
Leadership Team
Ana Karin Kusnetzow
Chief Scientific Officer
Istvan Molnar
Chief Medical Officer
Recent News
AstuteAnalytica India Pvt. Ltd.
2025-10-23
Company data provided by crunchbase